138 related articles for article (PubMed ID: 23548225)
41. Total laparoscopic surgery of cystic adenomyoma under hydroultrasonographic monitoring.
Nabeshima H; Murakami T; Terada Y; Noda T; Yaegashi N; Okamura K
J Am Assoc Gynecol Laparosc; 2003 May; 10(2):195-9. PubMed ID: 12732771
[TBL] [Abstract][Full Text] [Related]
42. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.
Bolla M; Gonzalez D; Warde P; Dubois JB; Mirimanoff RO; Storme G; Bernier J; Kuten A; Sternberg C; Gil T; Collette L; Pierart M
N Engl J Med; 1997 Jul; 337(5):295-300. PubMed ID: 9233866
[TBL] [Abstract][Full Text] [Related]
43. Use of goserelin in the treatment of breast cancer.
Rody A; Loibl S; von Minckwitz G; Kaufmann M
Expert Rev Anticancer Ther; 2005 Aug; 5(4):591-604. PubMed ID: 16111461
[TBL] [Abstract][Full Text] [Related]
44. [Effectiveness and tolerance of a gonadotropin releasing hormone (goserelin) in treatment of symptomatic endometriosis].
Wenzl R; Schultes G; Stummvoll W; Wieser F; Husslein P
Wien Klin Wochenschr; 1999 Apr; 111(7):283-8. PubMed ID: 10355039
[TBL] [Abstract][Full Text] [Related]
45. Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids.
Thomas EJ
Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():18-21. PubMed ID: 8916983
[TBL] [Abstract][Full Text] [Related]
46. Administration of goserelin acetate after uterine artery embolization does not change the reduction rate and volume of uterine myomas.
Vilos GA; Vilos AG; Abu-Rafea B; Pron G; Kozak R; Garvin G
Fertil Steril; 2006 May; 85(5):1478-83. PubMed ID: 16579996
[TBL] [Abstract][Full Text] [Related]
47. The long-term results with delayed-combined androgen blockade therapy in local or locally advanced prostate cancer.
Soga N; Hori Y; Ogura Y; Hayashi N; Sugimura Y
Jpn J Clin Oncol; 2012 Jun; 42(6):534-40. PubMed ID: 22438406
[TBL] [Abstract][Full Text] [Related]
48. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF; McNeill E; Young D; Donaldson MD
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[TBL] [Abstract][Full Text] [Related]
49. Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.
Sverrisdóttir A; Fornander T; Jacobsson H; von Schoultz E; Rutqvist LE
J Clin Oncol; 2004 Sep; 22(18):3694-9. PubMed ID: 15365065
[TBL] [Abstract][Full Text] [Related]
50. Juvenile cystic adenomyoma in a 19-year-old woman: a case report with a proposal for new diagnostic criteria.
Chun SS; Hong DG; Seong WJ; Choi MH; Lee TH
J Laparoendosc Adv Surg Tech A; 2011 Oct; 21(8):771-4. PubMed ID: 21561337
[TBL] [Abstract][Full Text] [Related]
51. Clinicopathologic characteristics of uterine adenomyoma in pregnant women.
Wang JH; He XH; Wu RJ; Xu XR
Fertil Steril; 2007 Jul; 88(1):172-5. PubMed ID: 17336979
[TBL] [Abstract][Full Text] [Related]
52. Gonadotropin-releasing hormone agonists for the management of ovarian cysts in menopause breast cancer patients on tamoxifen treatment.
Kourounis G; Zervoudis S; Michail G; Fotopoulos A
Breast J; 2005; 11(5):365-6. PubMed ID: 16174165
[No Abstract] [Full Text] [Related]
53. Successful total laparoscopic cystic adenomyomectomy after unsuccessful open surgery using transtrocar ultrasonographic guiding.
Nabeshima H; Murakami T; Nishimoto M; Sugawara N; Sato N
J Minim Invasive Gynecol; 2008; 15(2):227-30. PubMed ID: 18312998
[TBL] [Abstract][Full Text] [Related]
54. Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain.
Al-Azemi M; Jones G; Sirkeci F; Walters S; Houdmont M; Ledger W
BJOG; 2009 Nov; 116(12):1646-56. PubMed ID: 19735378
[TBL] [Abstract][Full Text] [Related]
55. [The role of GnRH agonists in the endoscopic treatment of endometriosis and fibromyomas].
Donnez J; Nisolle M; Grandjean P; Gillerot S; Clerckx F
Contracept Fertil Sex; 1993 Jan; 21(1):59-62. PubMed ID: 7951597
[TBL] [Abstract][Full Text] [Related]
56. Uterine artery embolization as a treatment option for uterine myomas.
Marshburn PB; Matthews ML; Hurst BS
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
[TBL] [Abstract][Full Text] [Related]
57. Genic expression of the uterine leiomyoma in reproductive-aged women after treatment with goserelin.
Borsari R; Bozzini N; Junqueira CR; Soares JM; Hilário SG; Baracat EC
Fertil Steril; 2010 Aug; 94(3):1072-7. PubMed ID: 19481745
[TBL] [Abstract][Full Text] [Related]
58. Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy.
Al-Shabibi N; Chapman L; Madari S; Papadimitriou A; Papalampros P; Magos A
BJOG; 2009 Apr; 116(5):681-7. PubMed ID: 19191779
[TBL] [Abstract][Full Text] [Related]
59. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas].
Nikolov A; Karag'ozov I
Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353
[TBL] [Abstract][Full Text] [Related]
60. Short term results from GHRH analogue use in pre-menopausal breast cancer in Korea.
Kim HJ; Lee JS; Park EH; Lim WS; Sei JY; Koh BS; Son BH; Ahn JH; Jeong KH; Kim SB; Ahn SH
Eur J Surg Oncol; 2009 Sep; 35(9):936-41. PubMed ID: 19269125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
